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The heart is densely innervated by sympathetic and vagal 
efferent as well as afferent fibers and the intrinsic gangli-
onated plexus which together control cardiac function on 
a beat-to-beat basis. The corresponding autonomic cardiac 
reflexes serve to adjust cardiac output according to the vari-
able needs of the circulation and thereby also control sys-
temic blood pressure. They are organized into local intrinsic 
and superposed spinal and central nervous system levels that 
closely interact with each other. Sensory fibers originating in 
the right atrium provide key afferent input to these reflexes 
and play a crucial role for the adjustment of sympathetic and 
vagal output directed to the heart.1,2 Autonomic atrial fibers 
and their neurochemical signalling are therefore of particu-
lar interest to cardiac physiology and pharmacology.3
Neurons of the intrinsic and extrinsic cardiac nervous 
system express various neuropeptides such as neuropeptide 
Y (NPY) and other small signalling molecules like nitric 
oxide (NO) acting as neuromodulators or cotransmitters 
during sympathetic and parasympathetic neurotransmis-
sion.3–5 Angiotensin (Ang) II is the central effector peptide 
of the renin–angiotensin–aldosterone system and an impor-
tant modulator of autonomic nervous function in the heart 
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BACKGROUND
The right atrium is densely innervated and provides sensory input to 
important cardiocirculatory reflexes controlling cardiac output and 
blood pressure. Its angiotensin (Ang) II-expressing innervation may 
release Ang II as a neuropeptide cotransmitter to modulate reflexes but 
has not yet been characterized.
METHODS
Intraoperative surgical biopsies from human right atria (n  =  7) were 
immunocytologically stained for Ang II, tyrosine hydroxylase (TH), and 
synaptophysin (SYN). Tissue angiotensins were extracted and quanti-
fied by radioimmunoassay.
RESULTS
Angiotensinergic fibers were frequent in epicardial nerves and around 
vessels with variable TH co-localization (none to >50%/bundle). Fibers 
were also widely distributed between cardiomyocytes and in the 
endocardium where they were typically nonvaricose, TH/SYN-negative 
and usually accompanied by varicose catecholaminergic fibers. In the 
endocardium, some showed large varicosities and were partially TH 
or SYN-positive. A few endocardial regions showed scattered nonvari-
cose Ang fibers ending directly between endothelial cells. Occasional 
clusters of thin varicose terminals co-localizing SYN or TH were located 
underneath, or protruded into, the endothelium. Endocardial density of 
Ang and TH-positive fibers was 30–300 vs. 200–450/mm2. Atrial Ang II, 
III, and I concentrations were 67, 16, and 5 fmol/g (median) while Ang IV 
and V were mostly undetectable.
CONCLUSIONS
The human right atrium harbors an abundant angiotensinergic inner-
vation and a novel potential source of atrial Ang II. Most peripheral fib-
ers were noncatecholaminergic afferents or preterminal vagal efferents 
and a minority was presumably sympathetic. Neuronal Ang II release 
from these fibers may modulate cardiac and circulatory reflexes inde-
pendently from plasma and tissue Ang II sources.
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where it facilitates presynaptic noradrenaline (NA) release.6–8 
Furthermore, it is an important neuropeptide cotransmitter in 
the central nervous system involved in the control of neuronal 
communication and central sympathetic nervous outflow.9
Recently, we and others found additional Ang II-positive 
neurons and fibers in dorsal root, trigeminal and coeliac gan-
glia of different species.10–13 We also provided evidence for an 
angiotensinergic co-phenotype of sympathetic fibers in the 
human kidney and heart where Ang II may serve as a neuro-
peptide cotransmitter.14–17 However, a detailed study of the dis-
tribution and characteristics of autonomic Ang II-expressing 
fibers in the human atria has not yet been performed. We 
hypothesized that neuronal Ang II expression is a relevant co-
phenotype of the atrial autonomic innervation and particularly 
of sympathetic fibers. Neuronal Ang II release from these fibers 
could possibly modulate cardiac reflex activity independently 
from tissue or plasma-derived Ang II. In the present investiga-
tion, we therefore studied the angiotensinergic innervation in 
surgical specimens from human right atria immunocytologi-
cally and measured atrial Ang peptide concentrations.
METHODS
Immunocytology
Discarded right atrial pieces from 7 male patients aged 57 to 
77 years who underwent cardiac bypass surgery were studied. 
Specimens (0.5–1.0 cm2) were obtained at the time of venous 
cannulation and immediately cooled (4 °C). One half was 
immersion fixed in phosphate buffered formaldehyde (2%) for 
3 days while the other was shock frozen in liquid nitrogen and 
stored at −80 °C for Ang determinations. Transmural cryostat 
sections (20–25 µm) were prepared for immunocytological 
stainings and incubated with primary antibodies using a free-
floating incubation technique.14 Detection of immunoreactive 
Ang II was with a mouse monoclonal IgG antibody that has 
been previously validated.10–12,14,15,18,19 These tests documented 
its specific binding to Ang II N-terminally linked to sepha-
rose.10 It does not detect Ang I, Ang (1–7) or angiotensino-
gen but recognizes Ang (2–8) [Ang III], Ang (3–8) [Ang IV], 
Ang (4–8) [Ang V], and Ang (2–10).10 A rabbit monoclonal 
antibody (clone EP1533Y; Epitomics, Burlingame, CA, 2129-1; 
1:200) was used for tyrosine 3-hydroxylase (TH), and mouse 
(SY38; Fitzgerald, Acton, MA, 10R-S124A; 1:600) and rabbit 
monoclonal antibodies (YE269; Epitomics, 1485-1; 1:400) for 
synaptophysin (SYN). Secondary labelling was with Cy3-tagged 
goat anti-mouse (Jackson ImmunoResearch, West Grove, PA, 
115-165-146; 1:600) or Cy5-labeled donkey anti-rabbit IgG 
antibodies (Jackson ImmunoResearch, 711-175-152; 1:300).
Simultaneous stainings were performed to detect co-locali-
zation of Ang II with TH or SYN. Nuclear DNA was visualized 
with 4′,6′-diamidino-2-phenylindole (DAPI). Test stainings 
with a polyclonal Ang II-antibody provided identical results 
(not shown). Furthermore, control assays without primary 
or secondary antibodies showed no specific staining. Leica 
DM6000B confocal fluorescent light and SP2 laser scanning 
microscopes were used for optical analysis by indirect immu-
nofluorescence and Leica imaging software. Endocardial 
fiber density per mm2 was determined by counting all vis-
ible fibers in the 2D optical plane multiplied by the thickness 
of the section. All procedures were in accordance with the 
Declaration of Helsinki and its amendments and performed 
with due permission from local authorities.
Angiotensin determinations
Atrial concentrations of Ang I  to V were determined 
according to a previously published protocol in all except 
one specimens too small for the procedure.14 The peptides 
were extracted from tissue homogenates and separated by 
high-pressure liquid chromatography before quantification 
by radioimmunoassay.20 Concentrations were expressed as 
fmol/gww. Detection levels were 0.24 and 0.48 fmol/gww for 
Ang II and I, respectively, and ~2 to 5 fmol/gww for the other 
peptides. Peptide recovery rates were >67%. Mean values 
with SDs were calculated and median values.
RESULTS
Immunoreactivity for Ang II was detected in atrial auto-
nomic nerve fibers and also in cardiomyocytes (Figures 1 
and 2). All specimens showed comparable and homogenous 
Ang II staining intensity in this respect. Ang II-positive 
fibers were present in all epicardial nerves and fiber bun-
dles together with TH-positive catecholaminergic fibers 
(Figure 2). The larger epicardial nerves further divided into 
smaller bundles and fascicles on their way to the periph-
ery and deeper atrial layers thereby following preformed 
anatomical septa (Figure  1a) or small arteries where they 
formed an adventitial network. In the epicardial nerves and 
large proximal bundles, Ang II-positive fibers were typi-
cally nonvaricose and their number usually comparable to 
that of TH-positive fibers (Figure 2). Co-localization of Ang 
II and TH immunoreactivity was variable between none to 
over 50% in a bundle and particularly frequent in epicardial 
nerves. It was occasionally present in fibers of the vascular 
adventitia and virtually absent in smaller bundles innervat-
ing the myocardium. The epicardial epithelium and subepi-
thelium were not innervated by Ang II-positive fibers.
In the myocardial layer, Ang II-positive fibers were ubiq-
uitously present between cardiomyocytes where they con-
tinued to be typically nonvaricose and negative for TH and 
SYN (Figure 3). They were usually seen in small groups of 2 
to 6 individuals and accompanied by up to 3 times as many 
exclusively TH-positive fibers with a thinner and highly vari-
cose shape (Figure 3d–f). Despite a comprehensive analysis 
of all specimens, no Ang II-positive varicose endings could 
be detected between cardiomyocytes. They were rarely vis-
ible in the adventitia of local vessels. No close synaptic con-
tacts between nerve fibers or with other cells were observed. 
SYN-positive and TH-positive fibers showed both a varicose 
morphology and comparable anatomical distribution while 
TH-positive fibers were generally SYN-positive. Finally, also 
cardiomyocytes showed intense Ang II staining (Figures 1a, 
b and 3a).
In the endocardium, several subtypes of Ang II-positive 
fibers could be distinguished (Figures 1b, d, e and 4). The 
first and by far most frequent type was seen in regions with 
flat endothelial cells where Ang fibers were nonvaricose, 
did not co-localize TH or SYN and ran in parallel with the 
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endocardial surface (Figures 1b and 4a, d; Supplementary 
Figure 1). They were observed singularly or in small groups 
and usually accompanied by highly varicose catecholaminer-
gic fibers (Figures 1c and 4c, f). Local clusters and loops could 
be observed (Figure 1b). These fibers always remained at a 
distance from the endothelial cell line. Another type was less 
frequent and characterized by large and spindle-shaped vari-
cosities. Such fibers were either TH-positive or TH-negative 
(Figure 4g–i). Occasionally, groups of multiple, very thin, 
and closely apposed Ang II-positive fibers exhibiting count-
less small varicosities with a characteristic flower spray or 
arachnoid appearance were observed that were also positive 
Figure 1. Sections from right atrial biopsies stained for angiotensin (Ang) II (red). (a) An overview picture showing atrial trabeculation with intensive 
Ang II-immunoreactivity in atrial cardiomyocytes (m) and in numerous nonvaricose fibers running in small bundles within the myocardium and the 
endocardium (e, closed arrowheads). (b) and (c) The endocardium at higher magnification after co-staining for Ang II (b) and synaptophysin (SYN; light 
green; c). A bundle of nonvaricose Ang II-positive fibers can be seen forming a loop in the subendothelial space (b). The fibers were accompanied by 
numerous thin and highly varicose SYN-positive fibers that can also be seen between cardiomyocytes (c). SYN immunoreactivity did not co-localize 
to the nonvaricose Ang-positive fibers. (d) Thin and varicose Ang-positive terminals protruding vertically into the endothelium that were additionally 
tyrosine hydroxylase (TH) positive (not shown). (e) Nonvaricose Ang II-positive yet TH and SYN-negative terminals interspersed between endothelial cells 
that could be found in some endocardial areas (overview and additional pictures in Supplementray Material). Dual channel confocal light microscopy. 
DNA staining with 4′,6′-diamidino-2-phenylindole (blue). Scale bars represent 50 µm (a), 25 µm (b, c, d), and 10 µm (e); lu, atrial lumen; dotted lines (d,e) 
indicate endothelial zone and luminal border.
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for SYN (Figure 4k–m). Still another type was found in areas 
with apparently high prismatic endothelial cells. These exclu-
sively Ang II-positive nonvaricose endings protruded verti-
cally between the endothelial cells while their tips attained 
the atrial luminal border (Figure 1e). Accompanying exclu-
sively double TH/SYN-positive varicose terminals were seen 
sticking out similarly into the endothelium (Supplementary 
Figures 2 and 3). Finally, in some areas, densely packed vari-
cose Ang II-positive terminals co-localizing TH protruded 
vertically into the endothelium (Figure 1d). The average 
density of endocardial Ang-positive fibers was estimated 
between 30 and 300/mm2 and that of catecholaminergic fib-
ers between 200 and 450/mm2, with great local variability.
Atrial Ang peptide concentrations are shown in Table 1. 
Ang II concentrations were highest followed by Ang III and 
Ang I with notable interindividual variability. On average, 
Ang III concentrations were ~1/3 of the Ang II concentra-
tions (median). Ang I concentrations were comparably low 
and Ang II/I and Ang II/III always >1. Ang IV and Ang V 
concentrations were mostly below the detection limit.
DISCUSSION
We found an abundant angiotensinergic innervation of 
the human right atrium with a widespread presence of Ang-
positive fibers in epicardial nerves and the myocardium and 
endocardium. In the epicardial nerves, TH and Ang co-expres-
sion was frequent. Peripheral Ang-positive fibers in the myo-
cardium and endocardium, instead, were mainly nonvaricose, 
noncatecholaminergic, and also SYN-negative with important 
exceptions notably in the endocardium and vessels. Next, Ang 
II could also be demonstrated intracellularly in cardiomyocytes. 
Atrial tissue Ang II and Ang III concentrations were high with 
respect to the other peptides including Ang I.  Functionally, 
neuronal Ang II release from these angiotensinergic fibers has 
implications as an independent source of atrial Ang II and a 
modulator of autonomic neurotransmission.
We relied on a highly sensitive monoclonal antibody and 
confocal or laser scanning microscopy to detect Ang II in tis-
sue sections at high resolution. This allowed us to differentiate 
closely apposed nerve fibers and their Ang II staining reliably. 
Previously, we and others have already detected angiotensiner-
gic neurons and fibers in rat and human spinal as well as sym-
pathetic ganglia.10–13 Furthermore, angiotensinergic neurons 
and fibers were found in human and rat cardiac autonomic 
ganglia and ventricles and finally also in the kidneys while 
showing a partial catecholaminergic co-phenotype.11,14,16,17 
Ventricular Ang II-positive fibers were infrequent. In contrast, 
we now document a comparably rich angiotensinergic inner-
vation of the human right atrium with local differences con-
cerning its catecholaminergic co-phenotype.
Studies of human cardiac transplants and in experimen-
tal animal have consistently demonstrated that the major-
ity of the cardiac innervation is of extrinsic origin leaving 
only a comparably limited innervation attributable to the 
intrinsic ganglionated plexus.21,22 Similar observations 
have been made in biopsies from human right atria and 
cardiac autopsy specimens where TH and NPY-positive 
intrinsic ganglionic neurons were usually rare.5,23–25 As 
Figure 2. Epicardial fiber bundle consisting of nonvaricose angioten-
sin (Ang) II-positive (red, a) and tyrosine hydroxylase (TH)-positive fib-
ers (green, b). (c) An overlay picture with co-localization of Ang II and 
TH immunoreactivity in numerous fibers (yellow). The arrow points to an 
exclusively Ang II-positive fiber next to adjacent exclusively TH-positive 
fibers. The arrowhead indicates a fiber with co-localization of Ang II 
and TH. There are Schwann cell nuclei visible between the fibers. Dual 
channel laser scanning microscopy. Staining of nuclear DNA was with 
4′,6′-diamidino-2-phenylindole (blue). Scale bar represents 10 µm.
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a vagal relay station, intrinsic cardiac neurons provide 
most of the postganglionic parasympathetic innerva-
tion with a typically cholinergic phenotype. Additionally, 
there are also numerous neurons with an afferent or 
interconnecting function.1,5,21,24 Some of the exclusively 
Ang II-positive atrial fibers in our study may thus have 
belonged to these intrinsic neurons. Nevertheless, most 
of the Ang II-positive and catecholaminergic innervation 
identified in our specimens was probably extrinsic to the 
heart.
Although neuronal Ang II is presumably derived from cel-
lular angiotensinogen expression coexisting with cathepsin 
D and converting enzyme expression to allow its generation 
and then transported to the periphery like other neuropep-
tides, neuronal Ang II uptake via AT1-receptors remains a 
theoretical possibility.4,10–12,15 Kushiku et  al.26 reported the 
presence of angiotensinogen messenger RNA expression 
in the canine inferior cervical and stellate ganglia that pro-
vide the main sympathetic efferent innervation of the heart. 
Expression of angiotensinogen messenger RNA and cellular 
Figure 3. Laser scanning micrographs of atrial myocardium stained for angiotensin (Ang) II (red, a, d, g, k) and co-stained for tyrosine hydroxylase (TH, 
green; b, e) or synaptophysin (SYN, green; h, l). The overlay pictures are shown in panels c, f, i, and m (co-localization yellow). (a–c) An overview picture. 
Numerous nonvaricose and exclusively Ang II-positive fibers can be seen between cardiomyocytes (m). Myocytes equally show intense Ang II staining (a). 
The fibers are accompanied by thin varicose and exclusively TH-positive fibers (b). (d–f) A magnification of the boxed area in panel c. (g–m) Ang II-positive 
fibers (arrow) next to cardiomyocytes that were accompanied by thin and highly varicose SYN-positive and presumably efferent fibers. DNA staining with 
4′,6′-diamidino-2-phenylindole (blue). Scale bars represent 50 µm (a–c), 10 µm (d–f, k–m), and 5 µm (g–i).
American Journal of Hypertension 31(2) February 2018 193
Angiotensinergic Atrial Innervation
Ang II immunoreactivity have also been described in the dor-
sal motor nucleus of the vagus suggesting that vagal motor 
fibers innervating the heart may equally express Ang II and 
contribute to its angiotensinergic innervation.27,28
Surprisingly, the vast majority of Ang II-positive fibers in 
the myocardium and endocardium did not co-localize TH 
and SYN suggesting that they were either afferents or possibly 
preterminal cholinergic efferents. Sensory fibers are usually 
negative for SYN, a marker of presynaptic vesicles, unless they 
are varicose. Such varicose terminals expressing SYN, calci-
tonin gene-related peptide or substance P have been detected 
in the human endocardium but were infrequent.29–32 In con-
trast, we could not identify varicose Ang II-expressing end-
ings between cardiomyocytes despite a comprehensive search 
Figure 4. Laser scanning micrographs of atrial endocardium stained for angiotensin (Ang) II (red, a, d, g, k) and co-stained for tyrosine hydroxylase (TH, 
green; b, h) or synaptophysin (SYN, green; e, l). (c, f, i, and m) Overlay pictures, respectively (co-localization yellow). (a–c) and (d–f) show nonvaricose and 
exclusively Ang II-positive fibers in the subendothelial space that were accompanied by varicose TH and SYN-positive fibers (see also Supplementary 
Figure 1). Ang II-positive cardiomyocytes (m) can bee seen in the vicinity. (g–i) Ang II-positive endocardial fibers characterized by large spindle-shaped 
varicosities that were either TH-positive (arrow) or negative (arrowhead). (k–m) A site with multiple thin and highly varicose Angiotensinergic fibers in a 
brush-like or arachnoid arrangement underneath the endothelium. The fibers were SYN-positive. SYN immunoreactivity was more extensive than that 
for Ang II. DNA staining with 4′,6′-diamidino-2-phenylindole (blue); atrial lumen indicated by ‘asterisk’. Scale bars represent 20 µm (a–c), 10 µm (g–i, k–m), 
and 5 µm (d–f).
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suggesting that they were rare at the most. Instead, catechola-
minergic fibers co-localizing Ang II were a frequent feature of 
epicardial nerves. They could have mainly belonged to inter-
ganglionic connections or possibly had non-atrial targets such 
as the large vessels or the ventricles to explain their relative 
paucity within the atrial myocardium and endocardium.
Detailed studies in humans and experimental animals have 
previously documented an extensive network of sympathetic 
and vagal efferent as well as sensory fibers covering the entire 
endocardium. These fibers may branch out and express a host 
of different neuropeptides.29–31,33 Moreover, they have been 
reported to keep at a distance from the endothelial cell line.30 
We now report nonvaricose exclusively Ang II-positive and also 
varicose exclusively TH-positive fiber terminals projecting into 
the endothelium itself. These endings were visible only on our 
cross sections of the atrial wall but may have been undetectable 
on typical whole-mount preparations with a plane view.21,29–31,33 
The endings probably belonged to Ang-expressing afferents 
and catecholaminergic sympathetic efferents and may release 
Ang II or monoamines locally for yet unknown purposes. Ang 
II-positive endings may furthermore display chemosensitive 
properties because of their proximity to the blood compart-
ment where they could readily sense molecules and gases dif-
fusing into the paracellular space. Indeed, most atrial afferent 
fibers have been characterized to be chemosensitive.34
We also observed highly varicose Ang II-positive endo-
cardial terminals with a catecholaminergic co-phenotype 
producing dense vertical palisades between endothelial 
cells with probably similar chemosensitive properties. Next, 
there were occasional Ang II-positive fibers in the endocar-
dium forming varicose and closely apposed SYN-positive 
flower spray endings. In rats, such fibers have been iden-
tified as terminal arborizations of vagal afferents.33 Finally, 
some angiotensinergic fibers with large, spindle-shaped 
varicosities were either TH-positive and probably sympa-
thetic or TH-negative and then possibly vagal motor fibers. 
In general, the endocardial density of Ang II-positive fibers 
was lower than that of TH-positive sympathetic fibers. We 
could not distinguish collaterals and many fibers may have 
finally belonged to a much smaller number of original feed-
ers. Our data therefore provide only preliminary estimates 
and cannot be compared unconditionally with others.30
Angiotensinergic fibers may release Ang II as a neuropep-
tide that would then hypothetically compete with Ang II of 
tissue origin for Ang receptor binding.4,15,35 Angiotensin recep-
tors (AT) have been documented on cardiac sympathetic and 
vagal fibers, intrinsic neurons, and also sensory fibers.7,8,36 Our 
immunocytological findings lend support to a new pathophys-
iological concept where cardiac autonomic fibers are not only 
a target of Ang II but may also act as an independent source of 
Ang II during neurochemical signalling.15 The close apposition 
of angiotensinergic and catecholaminergic fibers in the atrial 
myocardium and endocardium was highly suggestive of Ang-
mediated cross-talk. Cardiac sympathetic and vagal motor fib-
ers may control their activity mutually by neurochemical NPY 
and NO signalling.3 Our observations strongly suggest, that 
the sympathovagal balance may be additionally modulated by 
neuronal Ang II. Such neurochemical fine tuning could help 
optimize the activity of intrinsic neuronal circuits or reset the 
long-term activity of higher nervous centers controlling car-
diac function and circulatory homeostasis.2,3,34
Cardiac angiotensins are compartmentalized at the intersti-
tial and intracellular level and depend on locally produced Ang 
II.35,37 Our determinations of human atrial Ang I, II, and III 
concentrations were comparable to published animal data.14,37 
The downstream metabolites Ang IV and V were mostly unde-
tectable. Interestingly, atrial Ang II concentrations were high-
est and Ang II/I ratios consistently >1 similar to the Ang profile 
in the kidneys.19 The high-atrial Ang II concentrations may be 
explained by an active Ang II-generating pathway with accu-
mulation in cardiomyocytes via AT1 receptor-mediated uptake 
thus protecting it from degradation.35,37 In contrast, efficient 
angiotensinase activity and tissue clearance into the blood 
stream may explain the low Ang IV and V concentrations. 
Neuronal Ang II could possibly influence the local interstitial 
Ang III/II ratio and the balance between cellular AT1 and AT2 
receptor activation.6 Moreover, the immunocytological detec-
tion of Ang II in cardiac tissue has thus far been methodologi-
cally difficult.38 We now provide clear experimental evidence 
for its presence within cardiomyocytes. The greater than usual 
thickness of the tissue slices and the free-floating incubation 
technique facilitated its detection.17
Of note, NPY concentrations were found to decrease by up 
to 50% and NA concentrations by >90% after experimental 
Table 1. Atrial angiotensin concentrations [fmol/gww] and ratios (n = 6)
Samplea Ang I (Ang 1–10) Ang II (Ang 1–8) Ang III (Ang 2–8) Ang IV (Ang 3–8) Ang V (Ang 4–8) Ang II/I Ang II/III
1 <5.5 441 9.3 2.8 5.1 >80 47.4
2 11 74 36 <2.1 <2.1 7 2.1
3 <3.5 46 15 <1.8 <1.8 >13 3.1
4 4.2 203 81 <1.6 <1.6 48 2.5
5 2.6 59 17 <0.82 <0.82 23 3.5
6 6.6 18 3.5 <2.9 <2.9 3 5.1
Mean ± SDb 6 ± 3 140 ± 160 27 ± 29 ND ND 29 ± 30 11 ± 18
Medianb 5 67 16 ND ND 18 3
Abbreviation: Ang, angiotensin; ND, not determined.
aThe detection limit is given where concentrations were unmeasurable.
bValues were calculated using the detection limits if applicable.
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cardiac sympathectomy.39 Day et  al.40 measured cardiac 
somatostatin concentrations in human hearts. They were 
reported to depend on the somatostatin-positive fiber den-
sity. The authors concluded that somatostatin release by the 
cardiac autonomic innervation could generate biologically 
relevant tissue concentrations. Therefore, it would not be 
surprising, if there were also a significant contribution of 
neuronal Ang II to its total amount in the heart. Enhanced 
neuronal Ang II spillover with increased cardiac Ang II 
exposure could become relevant in situations with pathologic 
neuronal overactivity.2
Some limitations of our study need to be addressed. Due 
to the paucity of material, we were unable to analyze the 
origins and phenotypes of Ang II-positive fibers in greater 
detail using additional immunocytological markers. Neither 
could we determine other relevant Ang peptides like Ang 
1–7, a ligand of AT2 and mas receptors, or tissue enzymes.6 
The presence of immunocytological Ang II, however, could 
be confirmed by our determinations of tissue Ang concentra-
tions. The Ang II-antibody showed cross-reactivity with Ang 
III to V. This effect, however, would not change fiber classi-
fications. Ang IV and V concentrations were extremely low 
and therefore unlikely to have interfered. The variable con-
tent of muscle tissue in the specimens was another possible 
source of bias during Ang quantification. The biopsies were 
from random sites and no inference can therefore be made 
with respect to atrial anatomy. Finally, clinical diagnoses and 
medical treatments could have influenced the neural phe-
notype or individual Ang concentrations. Nevertheless, our 
findings were consistent across all biopsies lending overall 
validity to our conclusions.
In conclusion, we provide immunocytological evi-
dence for an abundant angiotensinergic innervation of the 
human right atrium that was mostly noncatecholaminer-
gic. Angiotensinergic fibers may serve as an independent 
neuronal Ang II source and possibly contribute to tissue 
Ang concentrations. Furthermore, neuronal Ang II may 
modulate the cardiac sympathovagal balance and adjust 
autonomic cardiac reflex activity with important implica-
tions for cardiac function and circulatory homeostasis. The 
exact functional role of angiotensinergic fibers in the heart, 
however, remains unclear and merits further experimental 
clarification.
SUPPLEMENTARY MATERIAL
Supplementary data are available at American Journal of 
Hypertension online.
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